Compare
Nu Skin Enterprises, Inc. vs Herbalife Ltd. vs Cosmos Health Inc. vs DataMeds AI, Inc.
| Latest fiscal year | Nu Skin Enterprises, Inc. NUS | Herbalife Ltd. HLF | Cosmos Health Inc. COSM | DataMeds AI, Inc. MEDS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.49B | $5.04B | $65.27M | $23.34M |
| Revenue growth (YoY) | -14.3% | +0.9% | +19.9% | +28.7% |
| Gross margin | 69.4% | 77.9% | 12.1% | -27.5% |
| Operating margin | 4.4% | 9.5% | -25.6% | -401.7% |
| Net margin | 10.8% | 4.5% | -29.3% | -433.9% |
| Net income | $160.20M | $228.30M | -$19.14M | -$101.27M |
| EPS (Diluted) | $3.18 | $2.20 | -$0.63 | -$1.43 |
| Operating cash flow | $80.29M | $333.30M | -$8.45M | -$10.86M |
| Free cash flow | $46.01M | $252.90M | -$8.50M | n/a |
| Cash & equivalents | $238.63M | $353.10M | $715.7K | $42.6K |
| Total assets | $1.41B | $2.79B | $65.48M | $30.46M |
| Total liabilities | $600.07M | $3.30B | $47.05M | $42.91M |
| Shareholders' equity | $805.24M | -$515.10M | $18.42M | -$12.45M |
| Return on year-end equity | 19.9% | n/a | -103.9% | n/a |
| Shares outstanding | n/a | 103.30M | 41.07M | 101.31M |
Revenue, most recent five fiscal years
| Fiscal year | Nu Skin Enterprises, Inc. | Herbalife Ltd. | Cosmos Health Inc. | DataMeds AI, Inc. |
|---|---|---|---|---|
| Latest | $1.49B Ended 2025-12-31 | $5.04B Ended 2025-12-31 | $65.27M Ended 2025-12-31 | $23.34M Ended 2025-12-31 |
| 1 year earlier | $1.73B Ended 2024-12-31 | $4.99B Ended 2024-12-31 | $54.43M Ended 2024-12-31 | $18.13M Ended 2024-12-31 |
| 2 years earlier | $1.97B Ended 2023-12-31 | $5.06B Ended 2023-12-31 | $53.38M Ended 2023-12-31 | n/a |
| 3 years earlier | $2.23B Ended 2022-12-31 | $5.20B Ended 2022-12-31 | $50.35M Ended 2022-12-31 | n/a |
| 4 years earlier | $2.70B Ended 2021-12-31 | $5.80B Ended 2021-12-31 | $56.24M Ended 2021-12-31 | n/a |